Success Metrics

Clinical Success Rate
100.0%

Based on 8 completed trials

Completion Rate
100%(8/8)
Active Trials
2(13%)
Results Posted
0%(0 trials)

Phase Distribution

Ph not_applicable
5
33%
Ph phase_1
2
13%
Ph phase_2
3
20%
Ph phase_4
4
27%
Ph phase_3
1
7%

Phase Distribution

2

Early Stage

3

Mid Stage

5

Late Stage

Phase Distribution15 total trials
Phase 1Safety & dosage
2(13.3%)
Phase 2Efficacy & side effects
3(20.0%)
Phase 3Large-scale testing
1(6.7%)
Phase 4Post-market surveillance
4(26.7%)
N/ANon-phased studies
5(33.3%)

Highest Phase Reached

Phase 4

Trial Status & Enrollment

Completion Rate

100.0%

8 of 8 finished

Non-Completion Rate

0.0%

0 ended early

Currently Active

2

trials recruiting

Total Trials

15

all time

Status Distribution
Active(2)
Completed(8)
Other(5)

Detailed Status

Completed8
unknown5
Recruiting2

Development Timeline

Analytics

Development Status

Total Trials
15
Active
2
Success Rate
100.0%
Most Advanced
Phase 4

Trials by Phase

Phase 12 (13.3%)
Phase 23 (20.0%)
Phase 31 (6.7%)
Phase 44 (26.7%)
N/A5 (33.3%)

Trials by Status

completed853%
recruiting213%
unknown533%

Recent Activity

2 active trials
Showing 5 of 15
recruitingnot_applicable

Intravenous Lidocaine Infusion Versus Intravenous Dexmedetomidine Infusion During Sleeve Gastrectomy

NCT07327905
recruitingphase_3

Minimizing ICU Neurological Dysfunction With Dexmedetomidine-induced Sleep (MINDDS II)

NCT06192615
completedphase_4

Nasal Packing Versus Intravenous Dexmedetomidine in Turbinate Surgeries

NCT05911776
unknownphase_4

Intranasal Dexmedetomidine Versus Intravenous Dexmedetomidine for Improving Quality of Endoscopic Sinus Surgery

NCT06081933
unknownnot_applicable

Nebulized Versus Intravenous Dexmedetomidine for Sevoflurane Induced Emergence Agitation After Pediatric Tonsillectomy

NCT05641376
View all 15 trials

Clinical Trials (15)

Showing 15 of 15 trials
NCT07327905Not Applicable

Intravenous Lidocaine Infusion Versus Intravenous Dexmedetomidine Infusion During Sleeve Gastrectomy

Recruiting
NCT06192615Phase 3

Minimizing ICU Neurological Dysfunction With Dexmedetomidine-induced Sleep (MINDDS II)

Recruiting
NCT05911776Phase 4

Nasal Packing Versus Intravenous Dexmedetomidine in Turbinate Surgeries

Completed
NCT06081933Phase 4

Intranasal Dexmedetomidine Versus Intravenous Dexmedetomidine for Improving Quality of Endoscopic Sinus Surgery

Unknown
NCT05641376Not Applicable

Nebulized Versus Intravenous Dexmedetomidine for Sevoflurane Induced Emergence Agitation After Pediatric Tonsillectomy

Unknown
NCT05604599Phase 4

Intranasal Versus Intravenous Dexmedetomidine for Hypotensive Anesthesia in FESS

Completed
NCT04266145Not Applicable

Intravenous Versus Perineural Dexmedetomidine as Adjuvant in Adductor Canal Block for Total Knee Arthroplasty

Completed
NCT03355534Not Applicable

Dexmedetomidine Improves Recovery After Cranial Aneurysm Surgery

Completed
NCT04618965Phase 4

Intrathecal Versus Intravenous Dexmeditomedine in Transurethral Resection of the Prostate

Unknown
NCT02730845Not Applicable

Intra-articular Versus Intravenous Dexmedetomidine in Arthroscopic Knee Surgeries Under Local Anesthesia

Completed
NCT01701778Phase 2

Caudal Versus Intravenous Dexmedetomidine for Supplementation of Caudal Analgesia in Children

Completed
NCT03293277Phase 1

Safety, Pharmacokinetics and Pharmacodynamics of Intranasal Dexmedetomidine in Healthy Subjects

Unknown
NCT02495220Phase 2

Efficacy of Dexmedetomidine for Postoperative Analgesia in Infantile Cataract Surgery

Unknown
NCT02416063Phase 2

Caudal Versus Intravenous Dexmedetomidine for Caudal Analgesia in Children

Completed
NCT00837187Phase 1

Bioavailability of Dexmedetomidine After Intranasal Administration

Completed

All 15 trials loaded

Drug Details

Intervention Type
DRUG
Total Trials
15